Nurix Therapeutics ( NASDAQ: NRIX ) announced that the chair of its board of directors, David L. Lacey, stepped down as board chair at the conclusion of today’s annual meeting of stockholders. The board of directors has unanimously elected board member Julia P.
Gregory as its new board chair. Source: Press Release More on Nurix Therapeutics Nurix Therapeutics Advances Promising Protein Degraders For B-Cell Malignancies Biggest stock movers today: JPM, APLD, and more Nurix Therapeutics prices upsized stock offering to raise $175 million Seeking Alpha’s Quant Rating on Nurix Therapeutics Historical earnings data for Nurix Therapeutics.
